Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review

NK Jain, M Tailang, HK Jain… - Frontiers in …, 2023 - frontiersin.org
Severe cases of COVID-19 are characterized by hyperinflammation induced by cytokine
storm, ARDS leading to multiorgan failure and death. JAK-STAT signaling has been …

Double-edged sword of JAK/STAT signaling pathway in viral infections: novel insights into virotherapy

M Mahjoor, G Mahmoudvand, S Farokhi… - Cell Communication and …, 2023 - Springer
The Janus kinase/signal transducer and activator of transcription (JAK/STAT) is an intricate
signaling cascade composed of various cytokines, interferons (IFN, growth factors, and other …

Recent advances in JAK inhibitors for the treatment of metabolic syndrome

D Collotta, MP Franchina, V Carlucci… - Frontiers in …, 2023 - frontiersin.org
With an epidemic spread, metabolic syndrome represents an increasingly emerging risk for
the population globally, and is currently recognized as a pathological entity. It is represented …

PARP7i Clinical Candidate RBN‐2397 Exerts Antiviral Activity by Modulating Interferon‐β Associated Innate Immune Response in Macrophages

X Du, J Zhou, Y Zhou, Y Chen, Y Kang… - Drug Development …, 2024 - Wiley Online Library
Polyadenosine diphosphate‐ribose polymerase 7 (PARP7) acts as a suppressor of the type
I interferon (IFN) signaling pathway via suppressing TANK‐binding protein 1 (TBK1) …

[HTML][HTML] Mechanistic Insights into Targeting SARS-CoV-2 Papain-like Protease in the Evolution and Management of COVID-19

NN Magwaza, AGA Mushebenge, SC Ugbaja… - BioChem, 2024 - mdpi.com
The COVID-19 pandemic, instigated by the emergence of the novel coronavirus, SARS-CoV-
2, created an incomparable global health crisis. Due to its highly virulent nature, identifying …

Infection of the oral cavity with SARS-CoV-2 variants: Scope of salivary diagnostics

P Iyer, T Chino, DM Ojcius - Frontiers in Oral Health, 2022 - frontiersin.org
Coronaviruses, including SARS-CoV-2, have caused pandemics in the past two decades.
The most prevalent SARS-CoV-2 variants of concern can re-infect individuals who have …

[HTML][HTML] Small molecule drug discovery targeting the JAK-STAT pathway

Y Lv, P Mi, JJ Babon, G Fan, J Qi, L Cao, J Lang… - Pharmacological …, 2024 - Elsevier
The Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway
functions as a central hub for transmitting signals from more than 50 cytokines, playing a …

[PDF][PDF] Infection-Simulator, Immunostimulatory and Immunomodulatory Effects of Interferons I and III in Biological Systems: A New Era in Vaccinology and Therapeutics …

TN Carp, M Metoudi, V Ojha - 2024 - preprints.org
The severe acquired respiratory coronavirus–2 (SARS–CoV-2) infection has initiated both
acute and chronic COVID–19 disease between 2020 and 2023, currently evolving with other …

Investigating the contribution of circulating inflammatory cytokines on the link between obesity and COVID-19

ZJ Khamis, E Karteris, A Alhajeri, SG Smith… - medRxiv, 2025 - medrxiv.org
Abstract Background: Coronavirus disease 2019 (COVID-19), is more severe in individuals
with obesity. Furthermore, a cytokine storm was observed in many critically ill patients with …

Low-Dose Interferon I and III-Based Nasal Sprays: A Good-Looking COVID-19 Vaccine Candidate and a Therapy of the Future?

TN Carp, M Metoudi, B Brown, V Ojha - 2023 - preprints.org
The SARS–CoV-2 infection has caused both acute and chronic COVID–19 disease during
the recent pandemic with emerging more transmissible SARS–CoV–2 Omicron variants …